Group items tagged

Barclays, the U.K. banking behemoth, is challenging Barclays To Host Blockchains Hackathon developers to assist refurbish the worldwide derivatives market next month at a hackathon. Disclosed to the media this week, DerivHack will take place at Barclays' Rise accelerator spaces at the same time in New York and London on September 20 and 21, 2018. The ISDA (International Swaps and Derivatives Association), Thomson Reuters, and Deloitte are co-sponsoring the hackathon.

Taking the assistance of TV channel broadcasting company can certainly be of great help to make the most out of your advertisement as well as attract potential customers towards your business in the least possible time.

October 24, 2008 - Google Tech Talks June 16, 2008 ABSTRACT Explore the brain's amazing ability to change throughout a person's life. This phenomenon-called neuroplasticty-is the science behind brain fitness, and it has been called one of the most extraordinary scientific discoveries of the 20th century. PBS had recently aired this special, The Brain Fitness Program, which explains the brain's complexities in a way that both scientists and people with no scientific background can appreciate. This is opportunity to learn more about how our minds work-and to find out more about the latest in cutting-edge brain research, from the founder of Posit Science and creator of the Brain Fitness Program software, Dr. Michael Merzenich. Speaker: Dr. Michael Merzenich, Ph.D. Michael M. Merzenich, PhD: Chief Scientific Officer Dr. Merzenich leads the company's scientific team. For more than three decades, Dr. Merzenich has been a leading pioneer in brain plasticity research. He is the Francis A. Sooy Professor at the Keck Center for Integrative Neurosciences at UCSF. Dr. Merzenich is a member of the National Academy of Sciences. He is the recipient of numerous awards and prizes, including the Ipsen Prize, Zulch Prize of the Max Planck Institute, Thomas Alva Edison Patent Award and Purkinje Medal. Dr. Merzenich has published more than 200 articles, including many in leading peer-reviewed journals, such as Science and Nature. His work is also often covered in the popular press, including the New York Times, the Wall Street Journal, Time and Newsweek. He has appeared on Sixty Minutes II, CBS Evening News and Good Morning America. In the late 1980s, Dr. Merzenich was on the team that invented the cochlear implant, now distributed by market leader Advanced Bionics. In 1996, Dr. Merzenich was the founding CEO of Scientific Learning Corporation (Nasdaq: SCIL), which markets and distributes software that applies principles of brain plasticity to assist children with language

Driving distractions such as cell phones and other electronic devices cause as much as 25% of all U.S. car accidents, researchers at the Governors Highway Safety Association have found, WinBETA notes. A major finding was that being distracted was the cause of 15 to 25% of all accidents, ranging from minor property damage to death. Their findings suggest that distracted driving accidents be reported in accident reports to assist in evaluating distracted driving laws and programs. They propose creating low-cost roadway measures that alert motorists when they are drifting out of their driving lane. They also propose that all cell phones be banned on the road, even hands-free versions. In another report by The New York Times, police in Syracuse and Hartford have handed out nearly 20,000 tickets for illegal use of a phone while driving - either for texting or use of a handheld phone. According to the federal government, these efforts have had the desired effect: distracted driving has fallen sharply. Their research shows that drivers talking on a phone are four times as likely to get into a crash as those not on a phone, and that the risks for motorists who text are at least twice as high. In Syracuse, handheld cellphone use and texting have each fallen by one-third. In Hartford, handheld cellphone use by drivers fell 57 percent while texting fell by 75 percent, the Times reports. Ref.: Vicki Harper. et al., Distracted Driving: What Research Shows and What States Can Do, GHSA, 2011

From proof-of-concept to post-marketing surveillance services, you can depend on our PV experts to efficiently work through the entire scope of Pharmacovigilance activities. We offer a high level of expertise and assist in meeting the highest standards of applicable national and global regulations. The experts at ACL Digital can easily customize safety monitoring services to suit your specific business requirements. Most biopharmaceutical companies have distinct and demanding clinical safety requirements as per the directions of regulatory agencies. You can depend on our PV specialists who plan safety and pharmacovigilance services accordingly that fit the needs of both your product and study - we adhere and adapt to your processes and are flexible enough to do it the right way.